LifeMD, Inc. (LFMD)

NASDAQ: LFMD · Real-Time Price · USD
3.830
-0.010 (-0.26%)
Nov 28, 2025, 1:00 PM EST - Market closed
-0.26%
Market Cap184.36M
Revenue (ttm)250.09M
Net Income (ttm)-11.13M
Shares Out 48.14M
EPS (ttm)-0.25
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume626,421
Open3.850
Previous Close3.840
Day's Range3.795 - 3.935
52-Week Range3.430 - 15.840
Beta1.33
AnalystsStrong Buy
Price Target10.22 (+166.84%)
Earnings DateNov 17, 2025

About LFMD

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company operates through two operating segments: Telehealth and WorkSimpli. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs, including erectile dysfunction, premature ejaculation, and hair loss; ShapiroMD that provides virtual medical treatment, prescription medications,... [Read more]

Sector Healthcare
Founded 1994
Employees 307
Stock Exchange NASDAQ
Ticker Symbol LFMD
Full Company Profile

Financial Performance

In 2024, LifeMD's revenue was $212.45 million, an increase of 39.27% compared to the previous year's $152.55 million. Losses were -$21.99 million, -7.23% less than in 2023.

Financial Statements

Analyst Summary

According to 9 analysts, the average rating for LFMD stock is "Strong Buy." The 12-month stock price target is $10.22, which is an increase of 166.84% from the latest price.

Price Target
$10.22
(166.84% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

LifeMD Recognized by the 2025 Deloitte Technology Fast 500™ and by TIME's America's Growth Leaders of 2026

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced it has been recognized on both the ...

5 days ago - GlobeNewsWire

LifeMD, Inc. (LFMD) Q3 2025 Earnings Call Transcript

LifeMD, Inc. ( LFMD) Q3 2025 Earnings Call November 17, 2025 4:30 PM EST Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Participants Da...

Other symbols: LFMDP
12 days ago - Seeking Alpha

LifeMD Stock Plummets After Q3 Earnings: Here's Why

LifeMD Inc. (NASDAQ: LFMD) shares fell after the company released its third-quarter earnings report after Monday's closing bell, missing analyst estimates on the top and bottom lines.

12 days ago - Benzinga

LifeMD Reports Third Quarter 2025 Results

Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% ...

Other symbols: LFMDP
12 days ago - GlobeNewsWire

LifeMD® to Offer Market-Leading Pricing for GLP-1 Medications Wegovy® and Ozempic® in Continued Collaboration with Novo Nordisk

LifeMD expands access to Wegovy and Ozempic at the lowest cash-pay pricing, reinforcing its commitment to patient affordability and high-quality care LifeMD expands access to Wegovy and Ozempic at the...

Other symbols: LFMDP
12 days ago - GlobeNewsWire

LifeMD to Participate in the BTIG Digital Health Forum

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy, today announced its participation in the virtual BTIG Digital...

Other symbols: LFMDP
19 days ago - GlobeNewsWire

LifeMD Reschedules Third Quarter 2025 Earnings Release and Conference Call to November 17

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services and pharmacy, today announced that the Company has rescheduled its third quar...

Other symbols: LFMDP
24 days ago - GlobeNewsWire

LifeMD Divests Majority Interest in WorkSimpli Software, Positioning Company as a Pure-Play Virtual Care and Pharmacy Platform

Transaction Values WorkSimpli at $65 Million Enterprise Value; Supports LifeMD's Strategic Focus on Scaling its Virtual Care and Pharmacy Businesses Transaction Values WorkSimpli at $65 Million Enterp...

Other symbols: LFMDP
25 days ago - GlobeNewsWire

LifeMD (LFMD) Faces Lawsuit Over Alleged Concealment of Cost and Refund Woes in Key Segments, According to Hagens Berman

LFMD Investors with Losses Encouraged to Contact Hagens Berman Before Oct. 27th Deadline SAN FRANCISCO , Oct. 24, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been file...

5 weeks ago - PRNewsWire

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding In LifeMD To Contact Him Directly To Discuss Their Options If you purchased or...

5 weeks ago - PRNewsWire

LifeMD to Report Third Quarter 2025 Financial Results on November 6

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, announces that it will report financial results for the three and nine mon...

5 weeks ago - GlobeNewsWire

LifeMD Names Dr. Tara Scott as Ambassador and Clinical Advisor for its Women's Health Program

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the appointment of Tara Scott, MD, widely known as “ The H...

5 weeks ago - GlobeNewsWire

LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance, According to Hagens Berman

Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.

6 weeks ago - GlobeNewsWire

LFMD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Faruqi & Faruqi, LLP Securities Litigation Partner  James (Josh) Wilson Encourages Investors Who Suffered Losses In LifeMD To Contact Him Directly To Discuss Their Options

6 weeks ago - GlobeNewsWire

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman

SAN FRANCISCO , Oct. 10, 2025 /PRNewswire/ -- A new federal securities fraud class action lawsuit has been filed against LifeMD (NASDAQ: LFMD), alleging that the telehealth company and its executives ...

7 weeks ago - PRNewsWire

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of October 25, 2025 in LifeMD, Inc. Lawsuit - LFMD

NEW YORK , Oct. 9, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of LifeMD, Inc. (NASDAQ: LFMD). Shareholders who purchased shares of LFMD during the class period...

7 weeks ago - PRNewsWire

LifeMD (LFMD) Sued for Allegedly Misleading Investors on Growth Guidance According to Hagens Berman

Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.

7 weeks ago - GlobeNewsWire

LIFEMD DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges LifeMD Investors to Contact the Firm Before the October 27th Deadline

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In LifeMD (LFMD) To Contact Him Directly To Discuss Their Options If you purchased or acquired...

7 weeks ago - GlobeNewsWire

LifeMD to offer Novo's Ozempic at $499 per month to eligible US cash-paying customers

Telehealth firm LifeMD said on Tuesday it would collaborate with Novo Nordisk to offer its diabetes drug Ozempic at $499 per month to eligible U.S. patients, including those who are insured and whose ...

Other symbols: NVO
2 months ago - Reuters

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk

NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk...

2 months ago - GlobeNewsWire

Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements According to Hagens Berman

Investors who lost money in LifeMD after its stock plunged 44 percent due to allegedly misleading financial statements are urged to contact Hagens Berman.

2 months ago - GlobeNewsWire

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4th Annual Healthcare Oppor...

Other symbols: LFMDP
2 months ago - GlobeNewsWire

LifeMD: Set To Ride A Telehealth Tailwind

LifeMD shares nearly halved in price following a missed earnings report, with subscriber retention being a key issue. LifeMD stock trades at a significant discount to HIMS despite similar subscription...

2 months ago - Seeking Alpha

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividen...

Other symbols: LFMDP
2 months ago - GlobeNewsWire

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In LifeMD To Contact Him Directly To Discuss Their Options

2 months ago - GlobeNewsWire